Terri B. Sebree, President at Zynerba Pharmaceuticals, Inc. (ZYNE), sold 24,661 shares at $0.60 ($15K) on 2023-01-23, disclosed to the SEC on 2023-01-25.
Open-market sale of $15k ZYNE by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ZYNE | BUY | 2018-08-07 | $22K | — | Filing → |